CAPTRUST FINANCIAL ADVISORS - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,00045
+164.7%
0.00%
Q4 2021$0
-100.0%
17
-93.6%
0.00%
Q3 2021$8,0000.0%2670.0%0.00%
Q2 2021$8,000
-33.3%
267
-6.0%
0.00%
Q1 2021$12,000
-91.6%
284
-90.8%
0.00%
-100.0%
Q4 2020$143,000
+2.9%
3,1000.0%0.00%0.0%
Q3 2020$139,000
+969.2%
3,100
+1140.0%
0.00%
Q2 2020$13,0002500.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 15,040$177,772,0000.69%
AlphaCentric Advisors LLC 50,000$591,0000.61%
Artemis Investment Management LLP 1,374,496$16,260,0000.18%
Knoll Capital Management, LLC 20,000$236,0000.14%
Game Plan Financial Advisors, LLC 11,280$133,0000.11%
Virtus ETF Advisers LLC 11,365$134,0000.05%
AllSquare Wealth Management LLC 5,527$65,0000.05%
Hennion & Walsh Asset Management, Inc. 34,231$405,0000.03%
Aquatic Capital Management LLC 10,000$118,0000.01%
Jump Financial, LLC 26,000$307,0000.01%
View complete list of BIOXCEL THERAPEUTICS INC shareholders